Marché mondial des tests de diagnostic – Tendances et prévisions de l’industrie jusqu’en 2031

Analyse et taille du marché des tests de diagnostic

L'un des principaux facteurs de croissance du marché est la prévalence croissante des maladies chroniques. En outre, le nombre croissant de tests IVD effectués dans le monde entier est un autre facteur clé de la croissance du marché. Les politiques de remboursement favorables influencent également le marché. Cependant, le coût élevé associé aux kits de diagnostic freine la croissance du marché. Les initiatives stratégiques des acteurs du marché constituent une opportunité de croissance du marché. Cependant, les règles et réglementations strictes pour l'approbation des kits de tests de diagnostic peuvent créer un défi pour le marché.

Data Bridge Market Research analyse que le marché mondial des tests de diagnostic devrait atteindre la valeur de 495,85 milliards USD d'ici 2031, contre 264,17 milliards USD en 2023, avec un TCAC de 8,4 % au cours de la période de prévision de 2024 à 2031.

Définition du marché

Les tests de diagnostic sont des procédures ou des dispositifs médicaux conçus pour identifier et déterminer la présence ou l'absence de maladies, d'affections ou de marqueurs spécifiques chez les individus. Ces tests jouent un rôle crucial dans les soins de santé en contribuant à la détection précoce, au diagnostic et au suivi de diverses pathologies.

Dynamique du marché mondial des tests de diagnostic

Cette section traite de la compréhension des moteurs, des avantages, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :

Conducteurs

• Prévalence croissante des maladies chroniques

Le nombre de maladies chroniques ne cesse d’augmenter dans le monde. Selon l’OMS (Organisation mondiale de la santé), en 2021, la contribution des maladies chroniques était d’environ 60 %, ce qui représentait le nombre de décès. Dans la plupart des pays occidentaux, l’augmentation du nombre de maladies chroniques est due à l’augmentation du nombre de personnes âgées. Ces taux croissants de maladies sont directement proportionnels à la croissance des tests de diagnostic, car ils sont utilisés pour diagnostiquer presque toutes les maladies.

À mesure que le taux de maladies chroniques augmente avec le temps, les facteurs associés à ces taux augmentent également. Avec l’augmentation des maladies, les soins de santé et l’état de santé s’améliorent également au fil du temps, et cela est dû à l’adoption et à l’augmentation du diagnostic de multiples maladies chroniques.

La prévalence croissante des maladies chroniques dans le monde est l'un des principaux moteurs de la croissance du marché des tests diagnostiques. Le besoin de diagnostics précis, opportuns et personnalisés pour gérer efficacement les maladies chroniques alimente l'innovation dans les technologies de diagnostic et favorise l'expansion du marché des tests diagnostiques pour répondre aux demandes évolutives en matière de soins de santé.

• Augmentation du nombre de tests IVD effectués dans le monde

Les diagnostics in vitro sont l'un des segments les plus importants du secteur de la santé. Ils sont considérés comme l'outil le plus important dans le monde du diagnostic, car ils aident au diagnostic précoce et à la prévention des maladies qui affectent la vie émotionnelle et personnelle du patient et qui pèsent également sur les finances. Ils sont utilisés dans le diagnostic du cancer, la prédiction des risques associés et autres.

The advancements associated with an increase in dependency due to the early detection of the diseases and the capability of predicting the disease before appearing & predicting the adverse effects of treatment due to the increase in the number of IVD tests are driving the market growth

Opportunity

• Strategic Initiatives by the Market Players

The increase in the burden load of chronic and non-chronic disease across the regions, with the increase in the geriatric population, has created more demand for developing new diagnostics kits and solutions with better efficacy and less time consumption. Their main aim is to improve the health management and diagnostics for quality performance. Their highest priority is to support the healthcare end users in diagnostics for better structural decisions. The market players are busy fulfilling the demands of healthcare professionals and spending a noticeable amount for better products, kits, and reagents among others.

These strategic initiatives by the government, including acquisition and focused segment product launches for different are helping them to expand the global reach and also helping them to expand and enhance the product portfolio of the company will ultimately lead to more revenue generation, hence these strategic initiatives by the market players are acting as an opportunity for market growth.

Restraint/Challenge

• Stringent Rules and Regulations for the Approval of Diagnostic Test Kits

The use of diagnostics kits across the globe is rapidly increasing, with the growth of the aged population and several diseases that are preventable by early diagnosis. At the same time, the players of the diagnostics kits and reagents in the market have to follow certain regulations to get approval from the upper authorities to launch the product in the market. These stringent guidelines need to be followed, and this is one of the most difficult tasks among all the steps.

Regulation of DNA test kits in the U.S. FDA, ensures the efficacy and safety of diagnostics kits, even during the manufacturing and at the time of storage of kits have specific guidelines; that is one of the major challenges for the players because kits need to be stored in a temperature range of -18 to -80 degree Celsius. If the FDA finds out that these guidelines are not mandated or followed, they may ban kits, which is considered one of the most stringent guidelines.

These guidelines by the FDA are one of the most challenging tasks for the players and also restrict other new plays from entering the market to satisfy these guidelines, it takes a good amount of capital which is very difficult to maintain for the mid and low level players, thus acting hampering the growth and acting as a challenge for global diagnostics market.

Recent Developments

• In May 2023, Roche officially announced the acquisition of Stratos Genomics. This acquisition led to the development of DNA based sequencing for diagnostics use. This enhanced the healthcare diagnosis segment of the company, thus leading to more revenue generation
• In April 2022, Bio-Rad Laboratories, Inc. officially announced that it acquired Celsee, Inc., which provides instruments for the analysis of cells and helps in diagnosis. This acquisition created an opportunity for both of them to launch new products, which will improve the company's product portfolio
• In September 2022, Abbott revolutionized continuous glucose monitoring (CGM) with the launch of the FreeStyle Libre 3 sensor. This sensor boasts a 14-day wear time, eliminating the need for finger pricking and offering patient’s real-time glucose data for better diabetes management. The Libre 3's extended wear time and improved user experience address major pain points for diabetic patients, potentially leading to increased market share and patient satisfaction.
• In March 2020, Roche got FDA approval for Elecsys GALAD. This approval enhanced the company's product segment and helped in the early diagnosis of carcinoma. This approval also enhanced the financials of the company
• In March 2020, Bio-Rad Laboratories, Inc. officially announced its partnership with Testing Labs Worldwide. This partnership helped in the diagnosis of various diseases, including COVID-19. This helped enhance the company's product portfolio.

Global Diagnostic Tests Market Scope

The global diagnostic tests market is segmented into eleven notable segments based on type, component, technology, mode of testing, application, sample type, testing site, testing type, age, end users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Routine Tests
• Specialized Tests

On the basis of type, the global diagnostic tests market is segmented into routine tests and specialized tests.

Component

• Services
• Products

On the basis of component, the global diagnostic tests market is segmented into services and products.

Technology

• Immunoassay-Based
• PCR-Based
• Next Gen Sequencing
• Spectroscopy-Based
• Chromatography-Based
• Microfluidics
• Others

On the basis of technology, the global diagnostic tests market is segmented into immunoassay-based, PCR-based, next gen sequencing, spectroscopy-based, chromatography-based, microfluidics, and others.

Mode of Testing

• Prescription-Based Testing
• OTC Testing

On the basis of mode of testing, the global diagnostic tests market is segmented into prescription-based testing and OTC testing.

Application

• Oncology
• Cardiology
• Orthopedics
• Gastroenterology
• Gynecology
• Neurology
• Odontology
• Others

On the basis of application, the global diagnostic tests market is segmented into oncology, cardiology, orthopedics, gastroenterology, gynecology, neurology, odontology, and others.

Sample Type

• Blood
• Urine
• Saliva
• Sweat
• Hair
• Others

On the basis of sample type, the global diagnostic tests market is segmented into blood, urine, saliva, sweat, hair, and others.

Testing Site

• Laboratory Based Testing
• At Home Testing

On the basis of testing site, the global diagnostic tests market is segmented into laboratory based testing and at home testing.

Testing Type

• Biochemistry
• Hematology
• Microbiology
• Histopathology
• Others

On the basis of testing type, the global diagnostic tests market is segmented into biochemistry, hematology, microbiology, histopathology, and others.

Age

• Geriatric
• Adult
• Pediatric

On the basis of age, the global diagnostic tests market is segmented into geriatric, adult, and pediatric.

End User

• Hospitals
• Diagnostic Center
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Homecare
• Blood Banks
• Research Labs & Institutes
• Others

On the basis of end user, the global diagnostic tests market is segmented into hospitals, diagnostic center, Ambulatory Surgical Centers (ASCs), specialty clinics, homecare, blood banks, research labs & institutes, and others.

Distribution Channel

• Direct Tenders
• Retail Sales
• Online Sales

On the basis of distribution channel, the global diagnostic tests market is segmented into direct tenders, retail sales, and online sales.

Global Diagnostic Tests Market: Regional Analysis/Insights

The global diagnostic tests market is analyzed and market size insights and trends are provided by country, type, component, technology, mode of testing, application, sample type, testing site, testing type, age, end users, and distribution channel.

The countries covered in this market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Turkey, Netherlands, Switzerland, Norway, Hungary, Austria, Lithuania, Ireland, rest of Europe, China, Japan, India, South Korea, Australia, Malaysia, Singapore, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, Colombia, Venezuela, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, and rest of Middle East and Africa.

North America is expected to dominate the global diagnostic tests market due to the increasing prevalence of chronic diseases. The U.S. is expected to dominate the North America diagnostic tests market owing to the higher level of investments by various manufacturers and increasing demand for pharmaceutical products manufacturing in the region. Germany is expected to dominate the Europe diagnostic tests market owing to the rising prevalence of chronic and infectious diseases. China is expected to dominate the Asia-Pacific diagnostic tests market owing to the increasing number of IVD tests across the globe.

La section par pays du rapport fournit également des facteurs individuels ayant un impact sur le marché et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques, l'analyse des cinq forces de Porter et les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Marché mondial des tests de diagnostic : paysage concurrentiel et analyse des parts de marché

Le paysage concurrentiel du marché mondial des tests de diagnostic fournit des détails sur le concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.

Certains des principaux acteurs du marché opérant sur le marché mondial des tests de diagnostic sont F. Hoffmann-La Roche Ltd, Abbott, Danaher, Siemens Healthineers AG, BD, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., EKF Diagnostics, ACON Laboratories, Inc. et BIOMEDOMICS INC. entre autres.

SKU-53717